Literature DB >> 17891838

Adjuvant mitotane in adrenocortical carcinoma.

Gabriel Dickstein, Carmela Shechner, Ofer Nativ.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891838

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experience.

Authors:  Clinton D Kemp; R Taylor Ripley; Aarti Mathur; Seth M Steinberg; Dao M Nguyen; Tito Fojo; David S Schrump
Journal:  Ann Thorac Surg       Date:  2011-10       Impact factor: 4.330

Review 2.  Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.

Authors:  Irina Veytsman; Lynnette Nieman; Tito Fojo
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

3.  Liver resection and ablation for metastatic adrenocortical carcinoma.

Authors:  R Taylor Ripley; Clinton D Kemp; Jeremy L Davis; Russell C Langan; Richard E Royal; Steven K Libutti; Seth M Steinberg; Bradford J Wood; Udai S Kammula; Tito Fojo; Itzhak Avital
Journal:  Ann Surg Oncol       Date:  2011-02-08       Impact factor: 5.344

4.  A G-CSF-secreting adrenal carcinoma with rhabdoid-like differentiation causing leukocytosis.

Authors:  Emil Lou; Jeremy Goodwin; David N Howell; John Hicks; L Brett Caram
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

5.  Adrenocortical carcinoma initially presenting with hypokalemia and hypertension mimicking hyperaldosteronism: a case report.

Authors:  Chun-Jui Huang; Ti-Hao Wang; Yuan-Hao Lo; Kuan-Ting Hou; Justin Ging-Shing Won; Tjin-Shing Jap; Chin-Sung Kuo
Journal:  BMC Res Notes       Date:  2013-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.